Loading data
IMNMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.94 m USD | 9.04 m USD | 14.02 m USD | — | — |
| Research and development expense | 177.29 m USD | 129.54 m USD | 23.09 m USD | 23.27 m USD | 14.11 m USD |
| Operating profit | -224.11 m USD | -305.8 m USD | -109.53 m USD | -36.9 m USD | -25.2 m USD |
| Net income (reported basis) | -212.39 m USD | -292.96 m USD | -106.81 m USD | -36.9 m USD | -24.71 m USD |
| Net income attributable to common shareholders | -212.39 m USD | -292.96 m USD | -106.81 m USD | -37.52 m USD | -24.71 m USD |
| Basic earnings per share | -2.43 USD/share | -5 USD/share | -5.38 USD/share | -3.09 USD/share | -2.14 USD/share |
| Diluted earnings per share | -2.43 USD/share | -5 USD/share | -5.38 USD/share | -3.09 USD/share | -2.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.